Piperine inhibits fungal growth and protects against pyroptosis in Aspergillus fumigatus keratitis by regulating the mTOR/HIF-1α pathway
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2025.114286 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Hong Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, Shandong Province 266003, China. Hauptthemen laut MEDLINE: Aspergillus fumigatus, Keratitis, Polyunsaturated Alkamides, Alkaloids. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
PURPOSE: To confirm the antifungal ability of piperine (PIP) and to assess its therapeutic potential in the treatment of Aspergillus fumigatus (A. fumigatus) keratitis. METHODS: The toxicity of PIP was measured to determine the optimal therapeutic concentration both in human corneal epithelial cells (HCECs), RAW264.7 cells and mice fungal keratitis models. The antifungal efficacy of PIP was confirmed through the minimum inhibitory concentration (MIC) test, biofilm formation inhibition test, Calcofluor white and PI staining, and anti-adhesion of A. fumigatus conidia test. Hematoxylin-eosin (HE) staining, corneal fungal load assay, RT-qPCR, western blot, and Elisa were used to assess the therapeutic effect and anti-inflammatory ability of PIP in fungal keratitis. The significance of the mTOR/HIF-1α signal pathway after PIP treatment of A. fumigatus keratitis was evaluated. RESULTS: PIP had no obvious toxicity to HCECs, RAW 264.7 cells, or mouse cornea at the concentration of 30 µg/mL. PIP effectively inhibited A. fumigatus from growing and showed synergistic effects when combined with NATA. PIP not only reduced fungal load and the aggregation of inflammatory cells, but also dramatically reduced the expression levels of NLRP3, caspase-1, cleaved caspase-1, GSDMD, GSDMD-N, IL-18, and IL-1β, which were linked to pyroptosis. Additionally, PIP decreased mTOR phosphorylation and HIF-1α expression. The pretreatment with mTOR agonists reversed the inhibition of NLRP3, caspase-1, cleaved caspase-1, GSDMD, GSDMD-N, IL-18, and IL-1β protein levels caused by PIP. CONCLUSION: PIP exhibited antifungal and anti-inflammatory properties, and alleviated pyroptosis in A. fumigatus keratitis via inhibiting the mTOR/HIF-1α signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, The Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, Shandong Province 266003, China.
- Department of Ophthalmology, The Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, Shandong Province 266003, China. Electronic address: yankelicui@126.com.
- Department of Ophthalmology, The Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, Shandong Province 266003, China. Electronic address: zhaoguiqiu_good@126.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, H., Yu, B., Lin, J., Wang, Q., Zhang, L., Li, Y., Liu, X., Liu, Y., Li, C., & Zhao, G. (2025). Piperine inhibits fungal growth and protects against pyroptosis in Aspergillus fumigatus keratitis by regulating the mTOR/HIF-1α pathway. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114286
Vancouver
Li H, Yu B, Lin J, Wang Q, Zhang L, Li Y, et al. Piperine inhibits fungal growth and protects against pyroptosis in Aspergillus fumigatus keratitis by regulating the mTOR/HIF-1α pathway. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114286
BibTeX
@article{Li2025,
author = {Li, Hong and Yu, Bing and Lin, Jing and Wang, Qian and Zhang, Lina and Li, Yuqi and Liu, Xiangzhi and Liu, Yuchen and Li, Cui and Zhao, Guiqiu},
title = {Piperine inhibits fungal growth and protects against pyroptosis in Aspergillus fumigatus keratitis by regulating the mTOR/HIF-1α pathway},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2025.114286}
}
EUVIMED